Patents Assigned to Sanguibiotech GmbH
  • Publication number: 20070148215
    Abstract: The invention relates to therapeutically active wound dressings based on polysaccharides, in particular chitosan, and protein, in particular collagen/gelatine, with improved properties, their manufacture, in particular the use of polycarbonic acids and polyfunctional amino acids, and their use, especially in the medical field.
    Type: Application
    Filed: November 30, 2004
    Publication date: June 28, 2007
    Applicant: SANGUIBIOTECH GMBH
    Inventors: Alexander Teslenko, Boris Nikonow, Sergej Antonow
  • Patent number: 7005414
    Abstract: According to the claims, the present invention comprises the preparation of chemically modified, cross-linked hemoglobins with improved functional properties, the cross-linked hemoglobins prepared according to this method and the use of these hemoglobins as artificial oxygen carriers. The synthesis method is characterized by technical simplicity as well as by high yields. Deoxygenated hemoglobin of high purity is conjugated covalently under the protection of an antioxidant with an effector of oxygen binding, especially with pyridoxal-5-phosphate, after which the hemoglobin is polymerized with glutardialdehyde as a bifunctional cross-linking agent. At the same time, there is a large increase in the volume of the reaction mixture and a decrease in the concentration of the hemoglobin during the addition of the cross-linking agent. Subsequently, after further dilution with water, a polyethylene oxide derivative is chemically linked to the cross-linked hemoglobins.
    Type: Grant
    Filed: June 12, 2001
    Date of Patent: February 28, 2006
    Assignee: Sanguibiotech GmbH
    Inventors: Wolfgang Barnikol, Oswald Burkhard, Harald Pötzschke, Ulrike Domack, Stephanie Dinkelmann, Bernd Fiedler, Birgit Manz
  • Patent number: 6956025
    Abstract: The invention relates to covalently cross-linked mammalian hemoglobins, to which polyalkylene oxides are covalently linked. Such hemoglobins are surprisingly compatible with proteins of human and animal plasma, under all the possible conditions within the vascular system of the body. The invention furthermore relates to the production of these cross-linked hemoglobins linked with polyalkylene oxides, as well as to their use as artificial intravasal oxygen carriers in the human or animal organism or in individual organs.
    Type: Grant
    Filed: June 2, 2001
    Date of Patent: October 18, 2005
    Assignee: Sanguibiotech GmbH
    Inventor: Wolfgang Barnikol